IV Vitamin Therapy at RE:BERRY Myeongdong Seoul

Pharmacokinetic Rationale for IV Vitamin Therapy

The foundational rationale for IV vitamin therapy is pharmacokinetics. Padayatty et al. (2004) demonstrated that oral vitamin C absorption saturates at 200mg daily because sodium-dependent vitamin C transporters (SVCT1/SVCT2) in intestinal epithelium are rate-limiting. In contrast, intravenous vitamin C achieves peak plasma concentrations of 13,000 micromol/L compared to just 220 micromol/L from oral routes — a 59-fold difference. This concentration gap allows vitamin C to function as a pro-oxidant at pharmacological levels, generating hydrogen peroxide in extracellular fluid and enhancing immune defense against pathogens.

Glutathione Bioavailability in IV Vitamin Therapy

Glutathione (gamma-glutamyl-cysteinyl-glycine) is the body’s primary endogenous antioxidant and phase II detoxification agent. Oral Glutathione suffers extensive first-pass hepatic metabolism with bioavailability of 3-5%. Allen and Bradley (2011) confirmed IV administration achieves 100% bioavailability with rapid distribution to liver, kidneys, and skin. At RE:BERRY Myeongdong, Glutathione IV vitamin therapy is the most requested formula, with first-visit sessions at ₩39,000 as an introductory experience.

The Myers’ Cocktail Legacy in IV Vitamin Therapy

Modern IV vitamin therapy protocols trace origins to the Myers’ Cocktail, developed by Dr. John Myers in the 1960s and documented by Gaby (2002). The original formula combined 2g magnesium, 0.5g calcium, B-complex, and 5g vitamin C for conditions ranging from migraines to fibromyalgia. Contemporary IV vitamin therapy at clinics like RE:BERRY Myeongdong expands this foundation significantly, incorporating 600-2,400mg Glutathione, 10mg zinc, 200mcg selenium, amino acids, and 300mg alpha-lipoic acid into specialized formulas.

High-Dose Vitamin C IV Therapy Safety

High-dose vitamin C IV vitamin therapy (above 15g) carries a specific safety consideration: patients with G6PD deficiency can develop hemolytic anemia at high doses. Levine et al. (2011) documented this risk, establishing the standard of pre-infusion G6PD enzyme screening. RE:BERRY Myeongdong follows this protocol 100% of the time, rejecting high-dose vitamin C IV therapy requests without prior G6PD testing. This safety-first approach reduces adverse event risk to near-zero.

B-Complex IV Vitamin Therapy for Cellular Energy

B-vitamins serve as cofactors for over 100 enzymatic reactions involved in energy metabolism, DNA synthesis, and nervous system function. Kennedy (2016) reviewed B-vitamin pharmacology and documented that intravenous administration achieves plasma concentrations 20-40x higher than oral routes, making IV vitamin therapy particularly effective for patients with malabsorption conditions or post-bariatric surgery. RE:BERRY Myeongdong’s B-complex IV vitamin therapy formula contains 100mg/mL thiamine, riboflavin, niacinamide, pyridoxine, and cobalamin.

Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537. doi:10.7326/0003-4819-140-7-200404060-00010

Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827-833. doi:10.1089/acm.2010.0716

Gaby AR. Intravenous nutrient therapy: the Myers’ cocktail. Altern Med Rev. 2002;7(5):389-403. doi:10.5555/uri:pii:S1089525302000347

Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2(2):78-88. doi:10.3945/an.110.000109

Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy — a review. Nutrients. 2016;8(2):68. doi:10.3390/nu8020068